The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer (Q28145081)

4

object named as

H Friess

0 references

author name string

J Kleeff

1

0 references

T Ishiwata

2

0 references

H Maruyama

3

0 references

P Truong

5

0 references

D Falb

7

0 references

M Korc

Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members

8

0 references

language of work or name

English

0 references

publication date

23 September 1999

0 references

published in

Oncogene

0 references

volume

18

0 references

issue

39

0 references

page(s)

5363-72

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Smad6 inhibits signalling by the TGF-beta superfamily.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Transforming growth factor beta1 induces nuclear export of inhibitory Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Loss of receptors for transforming growth factor beta in human T-cell malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Overexpression of human cyclin D1 reduces the transforming growth factor beta (TGF-beta) type II receptor and growth inhibition by TGF-beta 1 in an immortalized human esophageal epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Identification of important regions in the cytoplasmic juxtamembrane domain of type I receptor that separate signaling pathways of transforming growth factor-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Transforming growth factor-beta: recent progress and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear str

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Tumor suppressing pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

TGF beta signals through a heteromeric protein kinase receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Adenovirus-mediated transfer of a truncated transforming growth factor-beta (TGF-beta) type II receptor completely and specifically abolishes diverse signaling by TGF-beta in vascular wall cells in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

7 January 2021

Prognostic significance of PAI-1 and uPA in cytosolic extracts obtained from node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

7 January 2021

Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

7 January 2021

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

7 January 2021

Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202909

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202909

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

3792087

1007097018

0 references

3792087

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference